Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CoCensys enters research agreements with Senju and Parke-Davis

Feb. 18, 1999

FDA says KeraVision's treatment for myopia approvable

Feb. 17, 1999

Patient enrollment completed in loteprednol/antibiotic combination study

Feb. 11, 1999

Sunrise LTK System PMA accepted for filing by FDA

Feb. 11, 1999

Emadine approved for conjunctivitis in Europe

Feb. 8, 1999

InSite Vision licenses novel glaucoma treatment to Pharmacia & Upjohn

Jan. 29, 1999

Pharmacia & Upjohn provides additional funding for Miravant's SnET2

Jan. 20, 1999

Different concentrations of olopatadine compared to placebo for preventing allergic conjunctivitis

Jan. 19, 1999

FDA advisory panel recommends conditional approval of first nonlaser surgical treatment for myopia

Jan. 14, 1999

Phase III study of PhotoPoint therapy in AMD enrolling patients

Jan. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...